Association of Kikuchi-Fujimoto's disease with SLE.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 18304938)

Published in Rheumatology (Oxford) on February 26, 2008

Authors

F Goldblatt, J Andrews, A Russell, D Isenberg

Articles by these authors

(truncated to the top 100)

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum (1996) 6.88

Numbers of deaths related to intrapartum asphyxia and timing of birth in all Wales perinatal survey, 1993-5. BMJ (1998) 5.68

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry (2005) 4.86

Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet (1999) 3.92

Characterization of two classes of small molecule inhibitors of Arp2/3 complex. Nature (2009) 3.83

Mortality in systemic lupus erythematosus. Arthritis Rheum (2006) 3.61

Thermolysin is a suitable protease for probing the surface of intact pea chloroplasts. Plant Physiol (1984) 3.47

Separation and characterization of inner and outer envelope membranes of pea chloroplasts. Proc Natl Acad Sci U S A (1981) 3.38

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32

Sensitivity of Haemophilus influenzae to antibiotics. Br Med J (1974) 3.27

Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis (2001) 2.69

A geriatric day ward in an English hospital. J Am Geriatr Soc (1970) 2.68

Amoxycillin--pharmacology, bacteriology and clinical studies. Br J Clin Pract (1972) 2.65

Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology (2009) 2.60

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52

The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents. J Antimicrob Chemother (1995) 2.49

Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. J Natl Cancer Inst (1995) 2.49

Expression of Cdx-2 in the mouse embryo and placenta: possible role in patterning of the extra-embryonic membranes. Dev Dyn (1995) 2.43

Family support and conflict: prospective relations to adolescent depression. J Abnorm Child Psychol (1997) 2.38

Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis (2004) 2.35

A community study of smoking in pregnancy. J Obstet Gynaecol Br Commonw (1972) 2.25

Symbiotic fungal associations in 'lower' land plants. Philos Trans R Soc Lond B Biol Sci (2000) 2.19

Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18

HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum (1989) 2.14

The influence of parent, sibling, and peer modeling and attitudes on adolescent use of alcohol. Int J Addict (1993) 2.11

Movement disorders with cerebral toxoplasmosis and AIDS. Mov Disord (1993) 2.03

Franco-British disparities in medicine. J R Soc Med (1981) 2.02

Strand displacement amplification and homogeneous real-time detection incorporated in a second-generation DNA probe system, BDProbeTecET. Clin Chem (1999) 2.01

Cost-effectiveness of treatment of early stage endometrial cancer. Gynecol Oncol (1999) 1.99

Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology (2008) 1.96

An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum (2005) 1.96

Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol (1999) 1.95

Leucocyte-vitamin-C content and clinical signs in the elderly. Lancet (1966) 1.92

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis (2007) 1.90

The "D" (13-15) trisomy syndrome: an analysis of 7 examples. Arch Dis Child (1966) 1.86

Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 1.84

Pharmacokinetics and tissue penetration of linezolid following multiple oral doses. Antimicrob Agents Chemother (2001) 1.84

Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med (1988) 1.72

Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol (2001) 1.69

Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum (2008) 1.65

Comparison of an elemental and polymeric enteral diet in patients with normal gastrointestinal function. Gut (1983) 1.60

In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus. J Clin Invest (1983) 1.50

Increased levels of antibodies to heat shock proteins with increasing age in Mrl/Mp-lpr/lpr mice. Br J Rheumatol (1995) 1.48

Treatment of hyperammonemia. Am J Dis Child (1967) 1.47

Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J Autoimmun (1991) 1.45

Effect of physiological mechanical perturbations on intact human myocardial repolarization. Cardiovasc Res (2000) 1.45

Hospital beds. Lancet (1971) 1.44

An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology (Oxford) (2006) 1.42

Autoimmune diseases--at the molecular level. Immunol Today (1993) 1.42

Problems associated with susceptibility testing of co-amoxiclav. J Antimicrob Chemother (1993) 1.39

Dug-up roots. Br Dent J (2001) 1.38

Usefulness of the presenting electrocardiogram in predicting myocardial salvage with thrombolytic therapy in patients with a first acute myocardial infarction. Eur Heart J (2002) 1.38

Congenital absence of permanent second molars. Br Dent J (1996) 1.38

A comparative study of radionuclide venography and contrast venography in the diagnosis of deep venous thrombosis. Aust N Z J Med (1993) 1.38

The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study. Ann Rheum Dis (2007) 1.37

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial. Gene Ther (2001) 1.37

A comparative analysis of disease-associated changes in the galactosylation of serum IgG. J Autoimmun (1989) 1.36

Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. J Rheumatol (1994) 1.35

Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival. Int J Radiat Oncol Biol Phys (2000) 1.34

Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol (1992) 1.34

Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum (2008) 1.34

Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis (2004) 1.32

Directed movement of chromosome arms and fragments in mitotic newt lung cells using optical scissors and optical tweezers. Exp Cell Res (1994) 1.32

Bacteriology and pharmacokinetics of the new amidino penicillin-mecillinam. J Antimicrob Chemother (1976) 1.32

Multisite kinetic models for CYP3A4: simultaneous activation and inhibition of diazepam and testosterone metabolism. Drug Metab Dispos (2001) 1.29

Outcome measures to be used in clinical trials in systemic lupus erythematosus. J Rheumatol (1999) 1.29

Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy (2011) 1.29

Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2009) 1.27

Hereditary hyperammonaemia. Brain (1970) 1.26

Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286. J Biol Chem (2000) 1.25

The Dundee out-of-hours cooperative: preliminary outcomes for the first year of operation. Br J Gen Pract (1997) 1.24

Acute neutropenia decreases inflammation associated with murine vaginal candidiasis but has no effect on the course of infection. Infect Immun (1998) 1.24

Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy. J Antimicrob Chemother (1999) 1.24

E (16-18) trisomy syndrome: analysis of 13 cases. Arch Dis Child (1965) 1.24

Influence of abode and season on the vitamin C status of the elderly. Gerontol Clin (Basel) (1966) 1.23

The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis. Springer Semin Immunopathol (1988) 1.23

Vitamin C supplementation in the elderly: a 17-month trial in an old persons' home. Br Med J (1969) 1.23

Predictors of lymphoma development in primary Sjögren's syndrome. Semin Arthritis Rheum (1998) 1.22

Ecological genomics in Daphnia: stress responses and environmental sex determination. Heredity (Edinb) (2007) 1.22

beta-arrestins regulate interleukin-8-induced CXCR1 internalization. J Biol Chem (1999) 1.21

Turn taking affects the quality of infant vocalizations. J Child Lang (1987) 1.21

Group A streptococcal brain abscess. Scand J Infect Dis (2001) 1.21

Efficient generation in vitro, from human peripheral blood cells, of monoclonal Epstein-Barr virus transformants producing specific antibody to a variety of antigens without prior deliberate immunization. Proc Natl Acad Sci U S A (1983) 1.20

Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. The Nambour Skin Cancer Prevention Study Group. Int J Cancer (2000) 1.19

Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis (2008) 1.19

ASW: a gene with conserved avian W-linkage and female specific expression in chick embryonic gonad. Dev Genes Evol (2000) 1.18

Expression of the alphavbeta6 integrin promotes migration and invasion in squamous carcinoma cells. J Invest Dermatol (2001) 1.18

Cannabis use in a general psychiatric population. Scott Med J (1997) 1.18

Prevalence of self-reported depression in patients with rheumatoid arthritis. Br J Rheumatol (1996) 1.17

The global diabetes model: user friendly version 3.0. Diabetes Res Clin Pract (2000) 1.17

Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus. J Autoimmun (1993) 1.17

Analysis of B-cell epitopes of the Ro/SS-A autoantigen. Immunol Today (1999) 1.17

Randomized, double-blind comparison of growth in infants receiving goat milk formula versus cow milk infant formula. J Paediatr Child Health (2005) 1.15

Biochemical characterization of canavalin, the major storage protein of jack bean. Plant Physiol (1982) 1.15

Functional anatomy and muscle moment arms of the pelvic limb of an elite sprinting athlete: the racing greyhound (Canis familiaris). J Anat (2008) 1.15

Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteers. Antimicrob Agents Chemother (1990) 1.14

Dysgammaglobulinaemia type IV C. Clin Exp Immunol (1967) 1.14

Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS). Lupus (2007) 1.13

Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology (2006) 1.13

Invasive zygomycosis due to Conidiobolus incongruus. Clin Infect Dis (1994) 1.12